Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Biochem Biophys Res Commun ; 457(4): 664-8, 2015 Feb 20.
Artigo em Inglês | MEDLINE | ID: mdl-25603048

RESUMO

Multidrug resistance (MDR) is the major cause of cancer treatment failure. The ATP-binding cassette-B1 (ABCB1) transporter, also known as MDR1 or P-glycoprotein, is thought to promote the efflux of drugs from cells. MDR is also associated with the multidrug resistance-associated protein 1 (ABCC1) and the lung resistance-related protein (LRP), a human major vault protein. Moreover, MDR has a complex relationship with lipids. The ABCB1 has been reported to modulate cellular cholesterol homeostasis. Conversely, cholesterol has been reported to modulate multidrug transporters. However, results reported to date are contradictory and confusing. The aim of this study was to investigate whether LDL, HDL, and serum deprivation could influence ABCB1, ABCC1, and LRP expression in a human doxorubicin-resistant uterine sarcoma cell line. ABCB1 and ABCC1 expression increased after 24 h of serum deprivation, and expression returned to basal levels after 72 h. LDL, depending on concentration, increased ABCB1, ABCC1, and LRP expression. ABCB1 expression increased at low HDL, and decreased at high HDL concentrations. We demonstrated that serum deprivation and lipoproteins, particularly LDL, modulated ABCB1 expression and, to a lesser extent, ABCC1 expression. This finding may link the phenomena of drug transport, cholesterol metabolism and cancer.


Assuntos
Resistencia a Medicamentos Antineoplásicos , Lipoproteínas HDL/metabolismo , Lipoproteínas LDL/metabolismo , Proteínas Associadas à Resistência a Múltiplos Medicamentos/genética , Sarcoma/tratamento farmacológico , Neoplasias Uterinas/tratamento farmacológico , Partículas de Ribonucleoproteínas em Forma de Abóbada/genética , Subfamília B de Transportador de Cassetes de Ligação de ATP/genética , Antibióticos Antineoplásicos/farmacologia , Linhagem Celular Tumoral , Doxorrubicina/farmacologia , Feminino , Regulação Neoplásica da Expressão Gênica , Humanos , Sarcoma/sangue , Sarcoma/genética , Sarcoma/metabolismo , Neoplasias Uterinas/sangue , Neoplasias Uterinas/genética , Neoplasias Uterinas/metabolismo , Útero/efeitos dos fármacos , Útero/metabolismo
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa